2seventy bio Inc (TSVT)
4.785
-0.22
(-4.30%)
USD |
NASDAQ |
May 17, 16:00
4.785
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Cash from Operations (TTM): -159.65M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -159.65M |
December 31, 2023 | -166.86M |
September 30, 2023 | -150.86M |
June 30, 2023 | -189.96M |
March 31, 2023 | -203.75M |
Date | Value |
---|---|
December 31, 2022 | -228.14M |
September 30, 2022 | -237.81M |
June 30, 2022 | -220.54M |
March 31, 2022 | -215.59M |
December 31, 2021 | -206.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-237.81M
Minimum
Sep 2022
-150.86M
Maximum
Sep 2023
-198.00M
Average
-205.30M
Median
Cash from Operations (TTM) Benchmarks
Bristol-Myers Squibb Co | 13.72B |
Johnson & Johnson | 23.19B |
Macrogenics Inc | -111.02M |
Akebia Therapeutics Inc | -25.28M |
Tango Therapeutics Inc | -120.93M |